Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.
Sexual disparities in the incidence and course of MS.
STAT3 Activates miR-155 in Th17 cells and Acts in Concert to Promote Experimental Autoimmune Uveitis.
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis.
Oligodendrogenesis from neural stem cells: Perspectives for remyelinating strategies.
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
[Vitamin D and multiple sclerosis].
A Discrete Choice Experiment to Determine Patient Preferences for Injection Devices in Multiple Sclerosis.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Elevated HSP27 levels during attacks in patients with multiple sclerosis.
Do Bugs Control Our Fate? The Influence of the Microbiome on Autoimmunity.
Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study.
An empowerment model of workplace support following disclosure, for people with MS.
Environmental factors and multiple sclerosis severity: a descriptive study.
Risk factors for increased multiple sclerosis susceptibility in the Iranian population.
MRI Study: Objective Olfactory Function and CNS Pathologies in Patients with Multiple Sclerosis.
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.
The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function.
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Effects of multiwalled carbon nanotubes on electrospun poly(lactide-co-glycolide)-based nanocomposite scaffolds on neural cells proliferation.
Selection and optimization of therapy for progressive type multiple sclerosis.
[Neurodegenerative process in multiple sclerosis and a possible neuroprotective effect of Β-interferon 1a (avonex).]
Exposure to anaesthetic agents does not affect multiple sclerosis risk.
Direct and indirect cost burden associated with multiple sclerosis relapses: Excess costs of persons with MS and their spouse caregivers.
Pages
« first
‹ previous
…
337
338
339
340
341
342
343
344
345
…
next ›
last »